23
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: lack of effect of L-carnitine supplementation

, , , &
Pages 179-184 | Received 13 Jun 1984, Accepted 02 Oct 1984, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Birger Fagher, Mario Monti, Peter Nilsson-Ehle & Hans Thysell. (1987) Reduced thermogenesis in muscle and disturbed lipoprotein metabolism in relation to thyroid function in haemodialysis patients. Scandinavian Journal of Clinical and Laboratory Investigation 47:1, pages 91-97.
Read now

Articles from other publishers (31)

Norihiro Nishioka, Yan Luo, Takuya Taniguchi, Tsuyoshi Ohnishi, Miho Kimachi, Roland CK Ng & Norio Watanabe. (2022) Carnitine supplements for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Hamidreza Raeisi-Dehkordi & Taulant Muka. (2020) Meta-analysis of l-carnitine supplementation on lipid profile and glycemic control: Inadequate search strategy and other methodological issues. Clinical Nutrition 39:6, pages 1975-1976.
Crossref
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi & Sakineh Shab-Bidar. (2020) Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Archives of Medical Research 51:1, pages 82-94.
Crossref
Moein Askarpour, Amir Hadi, Michael E. Symonds, Maryam Miraghajani, Omid Sadeghi, Ali Sheikhi & Ehsan Ghaedi. (2019) Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials. Nutrition, Metabolism and Cardiovascular Diseases 29:11, pages 1151-1167.
Crossref
Jia-Lang Zheng, Li-Bin Peng, Qing-Ling Zhu, Xiao-Lin Zhang & Wei Hu. (2019) Waterborne zinc induced lobe-dependent effect on oxidative stress and energy metabolism in hepatopancreas of Larimichthys crocea. Aquatic Toxicology 215, pages 105270.
Crossref
Yizhi Chen, Manuela Abbate, Li Tang, Guangyan Cai, Zhixiang Gong, Ribao Wei, Jianhui Zhou & Xiangmei Chen. (2014) l-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis. The American Journal of Clinical Nutrition 99:2, pages 408-422.
Crossref
Haohai Huang, Lijun Song, Hua Zhang, Hanbin Zhang, Jiping Zhang & Wenchang Zhao. (2013) Influence of L-Carnitine Supplementation on Serum Lipid Profile in Hemodialysis Patients: A Systematic Review and Meta-Analysis. Kidney and Blood Pressure Research 38:1, pages 31-41.
Crossref
Alaa A. Sabry, Osama Ghaith, Tarek Medhat, Shahir K. George & Eid E. Elshafey. (2009) Is there a Role for Oral L-Carnitine Therapy in Anemia and Cardiac Dysfunction Management in Egyptian Patients on Maintenance Hemodialysis?. Electronic Journal of General Medicine 6:2, pages 60-68.
Crossref
Suhail Ahmad. 2009. Manual of Clinical Dialysis. Manual of Clinical Dialysis 199 209 .
Kefah Al-Hayk & Tulio E. Bertorini. (2007) Neuromuscular Complications in Uremics: A Review. The Neurologist 13:4, pages 188-196.
Crossref
Jia Liu, Kambiz Kalantarinia & Mitchell H. Rosner. (2006) Endocrinology and Dialysis: Management of Lipid Abnormalities Associated with End-Stage Renal Disease. Seminars in Dialysis 19:5, pages 391-401.
Crossref
Jeffrey S. Berns. (2006) How Can Erythropoietin Requirements be Reduced in Dialysis Patients?. Seminars in Dialysis 19:5, pages 370-372.
Crossref
S. Susan Hedayati. (2006) HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Dialysis-Related Carnitine Disorder. Seminars in Dialysis 19:4, pages 323-328.
Crossref
Jeffrey S. Berns & Ari Mosenkis. (2005) Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis. Hemodialysis International 9:1, pages 7-22.
Crossref
Drukker, Parsons & MaherW. H. Hörl. 2004. Replacement of Renal Function by Dialysis. Replacement of Renal Function by Dialysis 927 963 .
. (2003) REFERENCES. American Journal of Kidney Diseases 41, pages S77-S91.
Crossref
Thomas A Golper, Simin Goral, Bryan N Becker & Craig B Langman. (2003) l-carnitine treatment of anemia. American Journal of Kidney Diseases 41, pages S27-S34.
Crossref
Jean-Marc Hurot, Michel Cucherat, Margaret Haugh & Denis Fouque. (2002) Effects of l-Carnitine Supplementation in Maintenance Hemodialysis Patients: A Systematic Review. Journal of the American Society of Nephrology 13:3, pages 708-714.
Crossref
Suhail Ahmad. (2001) L‐Carnitine in Dialysis Patients. Seminars in Dialysis 14:3, pages 209-217.
Crossref
. (2000) I. Adult guidelines. American Journal of Kidney Diseases 35:6, pages s17-s104.
Crossref
Linda FriedAlastair HutchisonBernd Stegmayr, Sarah Prichard & Joanne M. Bargman. (2020) Recommendations for the Treatment of Lipid Disorders in Patients on Peritoneal Dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19:1, pages 8-17.
Crossref
REZAN TOPALOǴLU, ALPAY ÇELIKER, ÜMIT SAATÇI, KAMER KLINÇ, AYÇIN BAKKALOǴLU, NESRIN BEşBAS & KÜRSdedilAT TOKEL. (2007) Effect of carnitine supplementation on cardiac function in hemodialyzed children. Pediatrics International 40:1, pages 26-29.
Crossref
Ziad A. Massy, Jennie Z. Ma, Thomas A. Louis & Bertram L. Kasiske. (1995) Lipid-lowering therapy in patients with renal disease. Kidney International 48:1, pages 188-198.
Crossref
Thomas A. Golper & Suhail Ahmad. (2007) L‐Carnitine Administration to Hemodialysis Patients: Has Its Time Come?. Seminars in Dialysis 5:2, pages 94-98.
Crossref
Suhail Ahmad, H. Thomas Robertson, Thomas A. Golper, Marsha Wolfson, Paul Kurtin, Lois A. Katz, Raimund Hirschberg, Robert Nicora, Donald W. Ashbrook & Joel D. Kopple. (1990) Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney International 38:5, pages 912-918.
Crossref
Thomas A. Golper, Marsha Wolfson, Suhail Ahmad, Raimund Hirschberg, Paul Kurtin, Lois Anne Katz, Robert Nicora, Don Ashbrook & Joel D. Kopple. (1990) Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney International 38:5, pages 904-911.
Crossref
Paul S. Kurtin. (2007) Carnitine Metabolism and Usage in Chronic Dialysis Patients. Seminars in Dialysis 3:3, pages 166-170.
Crossref
Peter Fürst, Anne Glöggler & Claudia Rössle. 1990. New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis. New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis 69 77 .
S. Rodriguez-Segade, C.Alonso de la Peña, J.M. Paz, D. Novoa, V. Arcocha, R. Romero & R. Del Rio. (1986) Carnitine deficiency in haemodialysed patients. Clinica Chimica Acta 159:3, pages 249-256.
Crossref
Barry S. Kendler. (1986) Carnitine: An overview of its role in preventive medicine. Preventive Medicine 15:4, pages 373-390.
Crossref
C. Wanner & W. H. Hörl. (1986) Potential role of carnitine in patients with renal insufficiency. Klinische Wochenschrift 64:13, pages 579-586.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.